Your browser doesn't support javascript.
loading
Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group.
Samur, Mehmet Kemal; Aktas Samur, Anil; Fulciniti, Mariateresa; Szalat, Raphael; Han, Tessa; Shammas, Masood; Richardson, Paul; Magrangeas, Florence; Minvielle, Stephane; Corre, Jill; Moreau, Philippe; Thakurta, Anjan; Anderson, Kenneth C; Parmigiani, Giovanni; Avet-Loiseau, Hervé; Munshi, Nikhil C.
Affiliation
  • Samur MK; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA.
  • Aktas Samur A; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Fulciniti M; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Szalat R; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA.
  • Han T; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Shammas M; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Richardson P; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Magrangeas F; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA.
  • Minvielle S; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Corre J; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Moreau P; Inserm UMR892, CNRS 6299, Université de Nantes, and Centre Hospitalier Universitaire de Nantes, Unité Mixte de Genomique du Cancer, Nantes, France.
  • Thakurta A; Inserm UMR892, CNRS 6299, Université de Nantes, and Centre Hospitalier Universitaire de Nantes, Unité Mixte de Genomique du Cancer, Nantes, France.
  • Anderson KC; University Cancer Center of Toulouse Institut National de la Santé, Toulouse, France.
  • Parmigiani G; Inserm UMR892, CNRS 6299, Université de Nantes, and Centre Hospitalier Universitaire de Nantes, Unité Mixte de Genomique du Cancer, Nantes, France.
  • Avet-Loiseau H; Celgene Corporation, Summit, NJ.
  • Munshi NC; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
J Clin Oncol ; 38(27): 3107-3118, 2020 09 20.
Article in En | MEDLINE | ID: mdl-32687451
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Stem Cell Transplantation / Multiple Myeloma Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Stem Cell Transplantation / Multiple Myeloma Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2020 Document type: Article Affiliation country: Country of publication: